Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 335Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1A Rare Case of Flavocoxid-Induced Pulmonary Fibrosis
Dimitrios Drekolias,Naga Vaishnavi Gadela,Philip Krupka,Jennifer Broess,Jason Jacob
Cureus.2020;()
[DOI]
2Adverse drug reactions in neonates: could we be documenting more?
Daniel B Hawcutt,Olya O’Connor,Mark A Turner
Expert Review of Clinical Pharmacology.2014;7(6)807
[DOI]
3Oxacillin-induced leukocytoclastic vasculitis
Meric Mericliler,Aya Shnawa,Dalya Al-Qaysi,Jorge Fleisher,Andrew Moraco
IDCases.2019;17(6)e00539
[DOI]
4Overview of important methods used for causality assessment of adverse drug events in pharmacovigilance
Pushpraj Prafulla Gawai 
Journal of Pharmacovigilance and Drug Research.2020;1(2)6
[DOI]
5Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy
Bushra Weidenbusch,Günther H.S. Richter,Marie Sophie Kesper,Monika Guggemoos,Katja Gall,Carolin Prexler,Ilya Kazantsev,Alexandra Sipol,Lars Lindner,Michaela Nathrath,Olaf Witt,Katja Specht,Frigga Beitinger,Carolin Knebel,Stuart Hosie,Rüdiger von Eisenhardt-Rothe,Wilko Weichert,Irene Teichert-von Luettichau,Stefan Burdach
Oncotarget.2018;9(29)20747
[DOI]
6Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective
Shashidhar Swamy,Meenakshi Mourya,Ganesh Kadhe,Amey Mane,Sandesh Sawant
Expert Opinion on Drug Safety.2015;14(9)1409
[DOI]
7Adverse drug reactions in high-risk pregnant women: A prospective study
Alfredo Dias de Oliveira-Filho,Antonio Emanuel Soares Vieira,Roberta Cruz da Silva,Sabrina Joany Felizardo Neves,Thiago Antonio Barros Gama,Ryane Vieira Lima,Wlisses Ramon Oliveira,Júlia Maria de Gonçalves Dias
Saudi Pharmaceutical Journal.2017;25(7)1073
[DOI]
8The role of general practitioner in the study of adverse drug reactions epidemiology in ambulatory care setting
Turabian JL
Archives of Community Medicine and Public Health.2019;25(7)003
[DOI]
9Suspected Adverse Drug Reactions From Corticosteroids: Analysis of Reported Notifications to the Portuguese Pharmacovigilance System
Cristel Gonçalves,Cristina Monteiro,Jorge Luiz Santos
The Journal of Clinical Pharmacology.2020;60(10)1367
[DOI]
10Suspected Adverse Drug Reactions From Corticosteroids: Analysis of Reported Notifications to the Portuguese Pharmacovigilance System
Vivekanandan Kalaiselvan,Shatrunajay Shukla,Santhanakrishnan Ramesh Kumar,Nikita Mishra,Pawan Kumar,Rajeev Singh Raghuvanshi
The Journal of Clinical Pharmacology.2021;60(10)1367
[DOI]
11Linezolid induced optic neuropathy, a serious yet reversible adverse effect: a case report
Ritesh Shah,Samir Lamichhane
European Journal of Medical Case Reports.2017;60(10)114
[DOI]
12Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System
Ji Sun,Xuanyu Deng,Xiaoping Chen,Juanjuan Huang,Siqiong Huang,Yanfei Li,Jinhui Feng,Jiyang Liu,Gefei He
Clinical Pharmacology & Therapeutics.2020;108(4)791
[DOI]
13Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System
Ming Q. Lu,Qinping Liao,Jianpeng Wang,Tao Lv
Clinical Pharmacology & Therapeutics.2015;108(4)533
[DOI]
14The Food and Drug Administration Biologics Effectiveness and Safety Initiative Facilitates Detection of Vaccine Administrations From Unstructured Data in Medical Records Through Natural Language Processing
Matthew Deady,Hussein Ezzeldin,Kerry Cook,Douglas Billings,Jeno Pizarro,Amalia A. Plotogea,Patrick Saunders-Hastings,Artur Belov,Barbee I. Whitaker,Steven A. Anderson
Frontiers in Digital Health.2021;3(4)533
[DOI]
15Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy
Jyoti Bhagatram Sharma,Manjunath Nookala Krishnamurthy,Ankita Awase,Amit Joshi,Vijay Patil,Vanita Noronha,Kumar Prabhash,Vikram Gota
Therapeutic Advances in Drug Safety.2021;12(4)204209862199128
[DOI]
16Comparison of different methods for causality assessment of adverse drug reactions
Sapan Kumar Behera,Saibal Das,Alphienes Stanley Xavier,Srinivas Velupula,Selvarajan Sandhiya
International Journal of Clinical Pharmacy.2018;40(4)903
[DOI]
17Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
Juliana Hey-Hadavi,Daniel Seekins,Melissa Palmer,Denise Coffey,John Caminis,Sandzhar Abdullaev,Meenal Patwardhan,Haifa Tyler,Ritu Raheja,Ann Marie Stanley,Liliam Pineda-Salgado,David L. Bourdet,Raul J. Andrade,Paul H. Hayashi,Lara Dimick-Santos,Don C. Rockey,Alvin Estilo
Drug Safety.2021;44(6)619
[DOI]
18A Structured Methodology to Assess Safety Signal Strength and Inform Causality Assessment
Tim Sullivan,Magnus Nord,Doug Domalik,Magnus Ysander,Richard P. Hermann
Pharmaceutical Medicine.2022;36(4)215
[DOI]
19Household medical waste disposal policy in Israel
Zohar Barnett-Itzhaki,Tamar Berman,Itamar Grotto,Eyal Schwartzberg
Israel Journal of Health Policy Research.2016;5(1)215
[DOI]
20Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia
H.S. Marshall,A.P. Koehler,B. Wang,M. A'Houre,M. Gold,H. Quinn,N. Crawford,N. Pratt,T.R. Sullivan,K. Macartney
Vaccine.2020;38(37)5914
[DOI]
21Polyarteritis nodosa. Diagnostic challenges in a patient with cutaneous vasculitis, psoriasis, psoriatic arthritis and pancytopenia: fatal progression after treatment with G-CSF
Paresh Jobanputra
Oxford Medical Case Reports.2016;2016(4)86
[DOI]
22Comparing Methods for Estimating Direct Costs of Adverse Drug Events
Hanna Gyllensten,Anna K. Jönsson,Katja M. Hakkarainen,Staffan Svensson,Staffan Hägg,Clas Rehnberg
Value in Health.2017;20(10)1299
[DOI]
23Severe skin rash associated with efavirenz and atazanavir: a case report in a rural health facility in Kenya
K. Irungu
Drugs & Therapy Perspectives.2019;35(1)43
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal